Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes

This study has been completed.

Study NCT00240422 Information provided by Boehringer Ingelheim Pharmaceuticals

First Received: October 14, 2005 Last Updated: September 29, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	July 2004
Estimated Primary Completion Date:	No date given